Extrawell Phar (00858.HK) had a net loss of HKD 162 million for the year.

On June 28th, Glory Medical announced that for the fiscal year ended on March 31, 2024, the company's revenue was HKD 59.1 million, compared to HKD 72.58 million in the same period last year; the annual loss was HKD 162 million, compared to a profit of HKD 130 million in the same period last year.

Gelonghui FinanceJun 28 11:02 ET

Express News | Extrawell Pharmaceutical - FY Revenue HK$59.1 Mln Vs HK$72.6 Mln

ReutersJun 28 10:49 ET

Express News | Extrawell Pharmaceutical - FY Loss Attributable HK$162.9 Mln Vs Profit HK$129.3 Mln

ReutersJun 28 10:49 ET

Express News | Extrawell Pharmaceutical Holdings FY Net Income HKD -162.9 Million

ReutersJun 28 10:46 ET

EXTRAWELL PHAR: ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2024

Hong Kong Stock ExchangeJun 28 10:46 ET · Announcements

Extrawell Pharmaceutical Warns of Swing to Loss in Fiscal Year 2024

Extrawell Pharmaceutical Holdings (HKG:0858) expects a loss of between HK$160 million and HK$165 million for the year ended March 31, as compared to a profit in the year-ago period, a filing posted on

MT NewswiresJun 25 09:15 ET